SMR (NuScale Power Corporation) may reap gains as insiders became active recently

NuScale Power Corporation’s recently made public that its Director FLUOR CORP unloaded Company’s shares for reported $33.39 million on Oct 07 ’25. In the deal valued at $40.68 per share,820,861 shares were sold. As a result of this transaction, FLUOR CORP now holds 87,900 shares worth roughly $3.45 million.

Then, FLUOR CORP sold 87,900 shares, generating $3,479,063 in total proceeds. Upon selling the shares at $39.58, the Director now owns 0 shares.

Before that, FLUOR CORP sold 854,033 shares. NuScale Power Corporation shares valued at $36,218,284 were divested by the Director at a price of $42.41 per share. As a result of the transaction, FLUOR CORP now holds 908,761 shares, worth roughly $35.66 million.

BofA Securities downgraded its NuScale Power Corporation [SMR] rating to an Underperform from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late September with a ‘”an Equal weight”‘ rating. RBC Capital Mkts began covering SMR with “Sector perform” recommendation on September 15, 2025. BofA Securities started covering the stock on August 21, 2025. It rated SMR as “a Neutral”.

Price Performance Review of SMR

On Friday, NuScale Power Corporation [NYSE:SMR] saw its stock fall -3.37% to $39.24. Over the last five days, the stock has lost -2.19%. NuScale Power Corporation shares have risen nearly 204.19% since the year began. Nevertheless, the stocks have risen 118.85% over the past one year.

How much short interest is there in NuScale Power Corporation?

A steep rise in short interest was recorded in NuScale Power Corporation stocks on 2025-09-30, dropping by -3.56 million shares to a total of 32.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 35.92 million shares. There was a decline of -11.0%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on July 25, 2025 when BNP Paribas Exane began covering the stock and recommended ‘”a Neutral”‘ rating along with a $41 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.